a good buy here .
GSK shingles vaccine shows benefits across all age groupsReuters
GSK shingles vaccine shows benefits across all age groups
Goldman Sachs analysts said in a report on Tuesday that efficacy across age groups gives HZ/su a meaningful edge over Zostavax, and GSK's product had the potential to achieve peak sales of around 1 billionpounds ($1.5 billion) a year.
10X Trading Signals
Apr. 28, 2015
( AGEN ) appears in full "break out" mode and could be in the early innings of a larger rally
Apr 6, 2015 ZSEBO KRISZTINA MOfficer 47,931 Direct Option Exercise at $1.12
and bankrupt LOL
Update on Advaxis Announces 1-for-125 Reverse Stock Split and Decrease in Authorized Shares of Common Stock
That's what it is folks.